Project Grant CE147186
- The Department of Defense's Defense Health Agency awarded a $3,188,604 Project Grant titled "USE OF HIGH-THROUGHPUT SEQUENCING OF THE IMMUNOGLOBULIN LOCI FOR REFINED RISK STRATIFICATION IN PEDIATRIC B-ALL" to Seattle Children's Hospital, doing business as Seattle Children's Research Institute. This grant, funded through the Military Medical Research and Development (CFDA 12.420) program, supports biomedical research related to military medicine, with a focus on cancer, neurological...
- This Project Grant award for $616,710.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the Children's Research Institute in Washington, D.C. in designing effective adoptive immunotherapy for high-risk pediatric medulloblastoma. The research aims to develop a rational combination with MRI-guided focused ultrasound technology to enhance this innovative cancer treatment approach. The award period runs from August 1, 2024...
- The U.S. Department of Labor's Employment and Training Administration awarded a $350,000 Project Grant under the Community Project Funding/Congressionally Directed Spending program (CFDA 17.289) to Seattle Children's Hospital, doing business as Seattle Children's Research Institute. The award, effective May 1, 2024 through April 30, 2027, will fund the organization's diverse pediatric research initiatives, including work in areas such as infectious diseases, cancer, neuroscience, and rare...
- This Project Grant from the Department of Health and Human Services' National Institutes of Health Office of the Director, under the Trans-NIH Research Support program (CFDA 93.310), provides $2,043,753 to the University of Wisconsin-Madison for the RESET project running from April 15, 2021 to March 31, 2022. The RESET project aims to increase safe in-person school attendance among children with medical complexity (CMC) through three complementary approaches. It will establish the feasibility of...
- Cincinnati Children's Hospital Medical Center received a $249,999 Project Grant award dated September 15, 2025, from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The research initiative, titled "Assessment of Smoldering Glial Activation in Pediatric-Onset MS by Novel Neuroimaging," will be conducted at the hospital's Cincinnati, Ohio location through September 14, 2027. This two-year project delivers advanced neuroimaging research...
- Federal Project Grant Award Summary The University of California, San Diego received a $454,942 Project Grant from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire a full-spectrum flow cytometer for the Human Embryonic Stem Cell Core Facility (HESCCF) at the Sanford Consortium for Regenerative Medicine (SCRM). The award, effective May 15, 2025 through May 14, 2026, funds the procurement of a Cytek Aurora full-spectrum...
- The Department of Health and Human Services (HHS) awarded the Childrens Hospital Medical Center, doing business as Children's Home Healthcare, a $1,260,000 Project Grant through the Congressional Directives program (CFDA 93.493) on September 30, 2023. This grant will fund the construction and renovation of healthcare facilities over a 3-year period ending on September 29, 2026. The Congressional Directives program supports a wide range of special projects and programs identified by Congress,...
- Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a $2.0 million Project Grant from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire and implement a Hamilton BIOS M10 robotic frozen storage unit for the Discover Together (DT) Biobank. The award, obligated on May 15, 2025, with an ultimate completion date of May 14, 2026, will fund the procurement and deployment of this automated...
- This Project Grant award of $434,993 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Children's Hospital Los Angeles. The funding supports research using high-throughput sequencing of the immunoglobulin loci to develop refined risk stratification methods for pediatric B-cell acute lymphoblastic leukemia (B-ALL). The project aims to advance understanding and treatment of this pediatric cancer, with an expected completion...
- Federal Grant Award Summary Cincinnati Children's Hospital Medical Center received a $642,000 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective August 13, 2025, with a completion date of July 31, 2028. The award supports development of an automated deep learning-based assessment pipeline for evaluating peripherally inserted...
COMMUNITY PROJECT FUNDING/CONGRESSIONALLY DIRECTED SPENDING - CONSTRUCTION - CHILDREN'S RESEARCH INSTITUTE ("CRI"), BASED WITHIN CHILDREN'S WISCONSIN (CHILDREN'S), ADVANCES PEDIATRIC MEDICAL RESEARCH IN WISCONSIN AND BEYOND, WITH MORE THAN 1,000 ACTIVE CLINICAL STUDIES, INCLUDING ~200 INTERVENTIONAL CLINICAL TRIALS, CURRENTLY UNDERWAY. CRI TAKES DISCOVERIES FROM THE LABORATORY AND CONVERTS THEM TO NEW THERAPIES, DIAGNOSTICS, AND OTHER INNOVATIONS AT PATIENTS' BEDSIDES. PEDIATRIC RESEARCH IS VITAL TO PROVIDING THE BEST CARE FOR KIDS TODAY AND INTO THE FUTURE. PEDIATRIC RESEARCHERS HAVE ACCESS TO CRI-SUPPORTED SHARED SERVICE CORES INCLUDE FLOW CYTOMETRY, AQUATICS (ZEBRAFISH), HISTOLOGY, TISSUE BANKING, MICROSCOPIC IMAGING, AND BIOSTATISTICS. CHILDREN'S REQUESTS AN APPROPRIATION OF $400,000 FOR THE PURCHASE OF A NEW FLOW CYTOMETER, A CRITICAL PIECE OF LABORATORY EQUIPMENT UTILIZED BY SEVERAL DIFFERENT CRI RESEARCH GROUPS, INCLUDING THOSE STUDYING PEDIATRIC CANCER AND IMMUNE DISORDERS. A FLOW CYTOMETER PROVIDES A WELL-ESTABLISHED METHOD TO IDENTIFY CELLS IN SOLUTION AND IS MOST COMMONLY USED FOR EVALUATING PERIPHERAL BLOOD, BONE MARROW AND OTHER BODY FLUIDS. FLOW CYTOMETRY STUDIES ARE USED TO IDENTIFY AND QUANTIFY THE CELLS OF THE IMMUNE SYSTEM AND TO CHARACTERIZE HEMATOLOGICAL MALIGNANCIES. FLOW CYTOMETRY HAS BEEN AROUND FOR APPROXIMATELY 30 YEARS AND HAS BEEN CRITICAL TO DEVELOPING TARGETED CANCER THERAPIES BY DETECTING MARKERS ON THE SURFACE OF CELLS. FUNDING FOR A NEW FLOW CYTOMETER WOULD HELP MITIGATE THE IMPACT OF THE COVID-19 PANDEMIC ON OUR RESEARCH ENDEAVORS AND HELP CHILDREN'S CONTINUE TO BE A LEADER IN DEVELOPING SURGICAL AND MONITORING INNOVATIONS, DIAGNOSTIC TOOLS AND NEW TREATMENTS TO IMPROVE THE HEALTH AND WELL-BEING OF KIDS IN WISCONSIN.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 11/16/23 | ||
| Not listed | $0 | 4/28/23 | ||
| Not listed | $0 | 4/28/23 | ||
| Not listed | $0 | 2/24/23 | ||
| Not listed | $0 | 2/24/23 |